These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6403152)

  • 1. New drugs in respiratory disorders: II.
    Flenley DC
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):955-9. PubMed ID: 6403152
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the treatment of respiratory disorders.
    Heaf PJ
    Practitioner; 1969 Oct; 203(216):453-9. PubMed ID: 4311091
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the clinical efficacy of erythromycin, amoxicillin and co-trimoxazole in the treatment of acute respiratory tract infections in paediatric patients.
    Bottone E; Baldini G; Macchia P; Soldateschi M; Fridlevski A
    Curr Med Res Opin; 1982; 8(2):67-74. PubMed ID: 6980775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myrin P in the combined treatment of tuberculosis].
    Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD; Zeliger LR; Elistratova NA
    Antibiot Khimioter; 2002; 47(6):22-7. PubMed ID: 12422644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of amoxycillin versus co-trimoxazole in respiratory tract infections.
    Sharma NG
    Indian J Chest Dis Allied Sci; 1984; 26(4):230-3. PubMed ID: 6400092
    [No Abstract]   [Full Text] [Related]  

  • 7. Report on the therapeutic results obtained with rifampicin.
    Böszörményi M
    Antibiot Chemother; 1970; 16():487-9. PubMed ID: 5523734
    [No Abstract]   [Full Text] [Related]  

  • 8. [Short-term chemotherapy of pulmonary tuberculosis. Bacteriologic results].
    Boulahbal F; Tazir M; Khaled S; Chaulet P; el Awadi Z
    Arch Inst Pasteur Alger; 1980; 54():162-72. PubMed ID: 6765476
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 11. Augmentin (amoxycillin-clavulanic acid) compared with co-trimoxazole in urinary tract infections.
    Fancourt GJ; Matts SG; Mitchell CJ
    Br Med J (Clin Res Ed); 1984 Jul; 289(6437):82-3. PubMed ID: 6428687
    [No Abstract]   [Full Text] [Related]  

  • 12. Changing role of co-trimoxazole in the treatment of recurrent urinary infections: a comparison with augmentin.
    Brumfitt W; Hamilton-Miller JM
    Br J Clin Pract; 1985 Sep; 39(9):346-51. PubMed ID: 3904797
    [No Abstract]   [Full Text] [Related]  

  • 13. Further data on augmentin and co-trimoxazole in the treatment of urinary tract infection.
    Matts SG; Fancourt GJ; Mitchell CJ; Gowers E; Boston PF
    Br J Clin Pract; 1985 May; 39(5):179-84. PubMed ID: 3907682
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapse rates in tuberculosis patients.
    de Villiers CL; Macnab MF
    S Afr Med J; 1995 Feb; 85(2):114-5. PubMed ID: 7597522
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical evaluation of clavulanate-potentiated amoxycillin in the management of moderate to severe respiratory tract infections.
    Anyanwu CH; Umeh BU
    J Int Med Res; 1988; 16(3):210-5. PubMed ID: 3044873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Clin Allergy; 1974 Mar; 4(1):1-12. PubMed ID: 4824569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Trimethoprim-sulfamethoxazole versus amoxycillin in the therapy of acute bacterial exacerbations in chronic non-specific respiratory tract diseases. A controlled study].
    Ramer P; Medici TC; Hatt RR; Unger S; Ronner B
    Schweiz Med Wochenschr; 1981 Nov; 111(48):1823-9. PubMed ID: 7034198
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of Augmentin and co-trimoxazole in the treatment of adult infections in general practice.
    Davies JG; Rose AJ; Walker GD
    Br J Clin Pract; 1982 Dec; 36(11-12):387-93, 403. PubMed ID: 6984654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].
    Sighart H; Opl G; Weirich H
    Wien Med Wochenschr; 1982 Nov; 132(22):559-61. PubMed ID: 7168180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.